Copyright
©The Author(s) 2022.
World J Clin Cases. Jul 26, 2022; 10(21): 7302-7313
Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7302
Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7302
Variables | DICH group (n = 26) | Non-DICH group (n = 133) | P value |
Age (yr) | 51.35 ± 12.08 | 53.89 ± 15.17 | 0.422 |
Male gender, n (%) | 17 (65.38) | 66 (49.62) | 0.141 |
Primary intracranial lesion, n (%) | 0.679 | ||
Traumatic brain injury | 6 (23.07) | 43 (17.29) | |
Intracranial hemorrhage | 5 (19.23) | 30 (22.56) | |
SAH (aneurysm rupture) | 10 (38.46) | 29 (21.80) | |
SAH (AVM rupture) | 0 (0) | 0 (0) | |
Cerebral infarction | 0 (0) | 0 (0) | |
Tumor | 2 (7.69) | 8 (6.02) | |
Infection | 0 (0) | 4 (3.01) | |
Primary hydrocephalus | 3 (11.54) | 19 (14.29) | |
Pre-Craniotomy, n (%) | 9 (34.62) | 56 (42.11) | 0.477 |
Pre-Decompression, n (%) | 8 (30.77) | 50 (37.59) | 0.508 |
Pre-EVD, n (%) | 16 (61.54) | 42 (31.58) | 0.004a |
Pre-Cranioplasty, n (%) | 2 (7.69) | 23 (17.29) | 0.350 |
LP pressure (mmH2O) | 141.54 ± 60.93 | 139.42 ± 64.94 | 0.878 |
CSF protein (g/L) | 0.56 ± 0.46 | 0.64 ± 0.60 | 0.509 |
CSF glucose (mmol/L) | 3.87 ± 1.45 | 3.88 ± 1.35 | 0.980 |
CSF nucleated cells (106/L) | 16.31 ± 20.16 | 11.68 ± 17.15 | 0.223 |
WBC (109/L) | 8.37 ± 3.10 | 7.97 ± 2.82 | 0.512 |
Neutrophils (109/L) | 5.55 ± 2.97 | 5.41 ± 2.63 | 0.810 |
Lymphocyte (109/L) | 1.89 ± 0.55 | 1.75 ± 0.59 | 0.237 |
NLR | 3.40 ± 2.79 | 3.48 ± 2.20 | 0.869 |
RBC (1012/L) | 4.04 ± 1.54 | 3.88 ± 0.69 | 0.407 |
HGB (g/L) | 112.88 ± 15.44 | 114.71 ± 18.15 | 0.631 |
PLT (109/L) | 276.31 ± 68.61 | 280.92 ± 102.98 | 0.827 |
PLR | 160.46 ± 69.01 | 184.02 ± 105.17 | 0.275 |
PT(s) | 11.64 ± 1.24 | 11.40±1.26 | 0.374 |
INR | 1.01 ± 0.11 | 0.99 ± 0.11 | 0.382 |
Fib (g/L) | 4.88 ± 7.40 | 3.67 ± 1.60 | 0.416 |
Potassium (mmol/L) | 3.85 ± 0.42 | 3.81 ± 0.43 | 0.680 |
Sodium (mmol/L) | 136.68 ± 5.19 | 138.34 ± 5.30 | 0.144 |
Calcium (mmol/L) | 2.23 ± 0.12 | 2.22 ± 0.17 | 0.796 |
Blood glucose (mmol/L) | 5.92 ± 1.45 | 6.17 ± 2.34 | 0.591 |
SBP (mmHg) | 137.46 ± 21.35 | 140.14 ± 24.84 | 0.609 |
DBP (mmHg) | 86.50 ± 13.22 | 85.71 ± 14.08 | 0.791 |
Hypertension, n (%) | 10 (38.46) | 49 (36.84) | 0.876 |
Other basic disease, n (%) | 3 (11.54) | 16 (12.03) | 1.000 |
Smoker, n (%) | 7 (26.92) | 31 (23.31) | 0.693 |
Prior Blood transfusion, n (%) | 6 (23.08) | 48 (36.09) | 0.200 |
Operation time (min) | 73.46 ± 34.58 | 74.35 ± 26.86 | 0.883 |
Location of VP shunt, n (%) | 0.250 | ||
Frontal | 23 (88.46) | 101 (75.94) | |
Occiptal | 3 (11.54) | 32 (24.06) | |
Other VP Complications, n (%) | 1 (3.85) | 10 (7.52) | 0.801 |
Brain edema around catheter, n (%) | 15 (57.69) | 34 (25.56) | 0.000a |
Pre-mRS, n (%) | 0.281 | ||
Low (0-2) | 8 (30.77) | 56 (42.11) | |
High (3-5) | 18 (69.23) | 77 (57.89) | |
Post-mRS, n (%) | 0.024 | ||
Low (0-2) | 9 | 77 | |
High (3-5) | 17 | 55 |
- Citation: Chen JC, Duan SX, Xue ZB, Yang SY, Li Y, Lai RL, Tan DH. Risk factors for delayed intracranial hemorrhage secondary to ventriculoperitoneal shunt: A retrospective study. World J Clin Cases 2022; 10(21): 7302-7313
- URL: https://www.wjgnet.com/2307-8960/full/v10/i21/7302.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i21.7302